Tech Company Financing Transactions

NextCure Funding Round

NextCure, operating out of New Haven, secured $21.5 million in funding from Affinity Asset Advisors, Ikarian Capital and Squadron Capital.

Transaction Overview

Company Name
Announced On
11/17/2025
Transaction Type
Venture Equity
Amount
$21,500,000
Round
Undisclosed
Investors

Affinity Asset Advisors (Lead Investor)

Ikarian Capital (Lead Investor)

Squadron Capital (Lead Investor)

Proceeds Purpose
NextCure intends to use the net proceeds from the offering for general working capital needs, extending the company's cash runway into the first half of 2027, which is beyond the planned first half of 2026, proof of concept data readouts of its two antibody drug conjugate (ADC) programs, SIM0505 (CDH6 ADC) and LNCB74 (B7-H4 ADC).

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
9000 Virginia Manor Rd. 200
New Haven, CT 20705
USA
Email Address
Overview
NextCure (Nasdaq: NXTC), launched in 2015, is a biopharmaceutical company focused on discovering and developing next generation immuno-oncology-based drugs. The Company is applying its proprietary platforms and know-how to identify novel and biologically relevant targets and develop first-in-class immunotherapy products.
Profile
NextCure LinkedIn Company Profile
Social Media
NextCure Company Twitter Account
Company News
NextCure News
Facebook
NextCure on Facebook
YouTube
NextCure on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Michael Richman
  Michael Richman LinkedIn Profile  Michael Richman Twitter Account  Michael Richman News  Michael Richman on Facebook
Chief Financial Officer
Steven Cobourn
  Steven Cobourn LinkedIn Profile  Steven Cobourn Twitter Account  Steven Cobourn News  Steven Cobourn on Facebook
Vice President
Linda Liu
  Linda Liu LinkedIn Profile  Linda Liu Twitter Account  Linda Liu News  Linda Liu on Facebook
VP - Bus. Development
James Bingham
  James Bingham LinkedIn Profile  James Bingham Twitter Account  James Bingham News  James Bingham on Facebook
VP - Bus. Development
Sebastien Maloveste
  Sebastien Maloveste LinkedIn Profile  Sebastien Maloveste Twitter Account  Sebastien Maloveste News  Sebastien Maloveste on Facebook
VP - Bus. Development
Timothy Mayer
  Timothy Mayer LinkedIn Profile  Timothy Mayer Twitter Account  Timothy Mayer News  Timothy Mayer on Facebook
VP - Regulatory Affairs
Sol Langermann
  Sol Langermann LinkedIn Profile  Sol Langermann Twitter Account  Sol Langermann News  Sol Langermann on Facebook


 

 

Browse more venture capital transactions:

Prev: 11/17/2025: No Barrier venture capital transaction
Next: 11/17/2025: KoBold Metals venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to record tech company VC transactions. VC transactions reported here come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary